DK0590150T3 - (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat - Google Patents

(-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat

Info

Publication number
DK0590150T3
DK0590150T3 DK92909279T DK92909279T DK0590150T3 DK 0590150 T3 DK0590150 T3 DK 0590150T3 DK 92909279 T DK92909279 T DK 92909279T DK 92909279 T DK92909279 T DK 92909279T DK 0590150 T3 DK0590150 T3 DK 0590150T3
Authority
DK
Denmark
Prior art keywords
azaspiro
oxa
decane
tartrate
methylene
Prior art date
Application number
DK92909279T
Other languages
English (en)
Inventor
Shin-Ichi - - Kasuga Tsukamoto
Takeru Sumitomojuutak Kohinata
Mitsuo - Kanbeeshinden I Fujii
Sakiko - Asahigaokama Tomizawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of DK0590150T3 publication Critical patent/DK0590150T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK92909279T 1991-05-15 1992-04-27 (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat DK0590150T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13961991 1991-05-15
PCT/JP1992/000548 WO1992020683A1 (fr) 1991-05-15 1992-04-27 L-tartrate de (-)-(s)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decane

Publications (1)

Publication Number Publication Date
DK0590150T3 true DK0590150T3 (da) 1999-04-19

Family

ID=15249510

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92909279T DK0590150T3 (da) 1991-05-15 1992-04-27 (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat

Country Status (11)

Country Link
US (1) US5403931A (da)
EP (1) EP0590150B1 (da)
AT (1) ATE168114T1 (da)
AU (1) AU1666392A (da)
CA (1) CA2109117A1 (da)
DE (1) DE69226187T2 (da)
DK (1) DK0590150T3 (da)
ES (1) ES2118814T3 (da)
GR (1) GR3027686T3 (da)
RU (1) RU2057132C1 (da)
WO (1) WO1992020683A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2168843C (en) * 1993-08-19 2004-10-19 Raymond Cvetovich Thermodynamically stable crystal form of 4"-deoxy-4"-epi-methylamino avermectin b1a/b1b benzoic acid salt and processes for its preparation
ES2368824T3 (es) * 1998-03-27 2011-11-22 Oregon Health & Science University Vitamina d y sus análogos en el tratamiento de tumores y otros desórdenes hiperproliferativos.
JP2003063964A (ja) * 2001-08-28 2003-03-05 Senju Pharmaceut Co Ltd ドライアイまたはドライアイを伴なう疾病の予防治療剤
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
KR20080031430A (ko) * 2005-07-26 2008-04-08 센주 세이야꾸 가부시키가이샤 경피적으로 흡수가능한 안과용 제제
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
KR20150116466A (ko) * 2009-01-26 2015-10-15 이스라엘 인스티튜트 포 바이올로지컬 리서치 이환형 헤테로사이클릭 스피로 화합물
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853758T2 (de) * 1987-10-05 1995-09-07 Yamanouchi Pharma Co Ltd Heterozyklische Spiroverbindungen und ihre Herstellung.
US5075317A (en) * 1989-06-21 1991-12-24 Fisons Corporation Spirofurane derivatives

Also Published As

Publication number Publication date
ES2118814T3 (es) 1998-10-01
CA2109117A1 (en) 1992-11-16
DE69226187T2 (de) 1998-10-22
EP0590150B1 (en) 1998-07-08
US5403931A (en) 1995-04-04
EP0590150A1 (en) 1994-04-06
DE69226187D1 (de) 1998-08-13
WO1992020683A1 (fr) 1992-11-26
GR3027686T3 (en) 1998-11-30
ATE168114T1 (de) 1998-07-15
AU1666392A (en) 1992-12-30
EP0590150A4 (en) 1994-06-29
RU2057132C1 (ru) 1996-03-27

Similar Documents

Publication Publication Date Title
DK0590150T3 (da) (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat
PT91553A (pt) Processo de preparacao de uma composicao contendo morfina
NO2002009I2 (no) Tiotropium
DE69213256D1 (de) Organische salze von n, n'-diacetylcystin
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
SG67901A1 (en) Preparation and use of salts of the pure enantiomers of alpha-lipoic acid
DE69109021D1 (de) Augentropfenarzneimittel.
DK232989A (da) Antiviralt praeparat
RU93058306A (ru) Моногидрат l-тартрата(-)-(s)-2,8-диметил-3-метилен-1-окса-8-азаспиро-(4,5)-декана
DE69002697D1 (de) Carboplatinzusammensetzung.
FI945510A0 (fi) Klavulaanihapon diamiinisuolat
DE59303616D1 (de) Verfahren zur Herstellung von Isoprenderivaten
DK297485D0 (da) Carbapenemer med kvaternaere heteroarylalkylthio 2-substituenter samt laegemiddel indeholdende saadanne forbindelser
DE69033442D1 (de) Optisch aktive Verbindungen mit mehreren chiralen Zentren und ihre Herstellung
NO179504C (no) Legemiddel i form av en tablett inneholdende diritromycin
DK0430551T3 (da) Behandling af hjertedysfunktion med 15-keto-prostaglandinforbindelser
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
FR2649116B1 (fr) Composition organopolysiloxane monocomposante a stabilite au stockage amelioree
DE3681856D1 (de) Pharmazeutische 2-oxopyrrolidinverbindungen, ihre salze und ihre herstellung.
ITVE910013A1 (it) Progetto di catamarano da competizione formula o. p. 1. a stabilita' idrodinamica indotta
ATE96025T1 (de) Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning
ATE148991T1 (de) Nicotinamid-adenin-dinukleodid enthaltendes antidepressionsmittel
ATE104986T1 (de) Aminsalze von 1,4,2-oxazaphospholidin-2-alkoxy-2oxid-4-essigs|uren.